logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5148.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5148.produseast1
Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon

Eyong J, Fai KN, Nikolay B, Gignoux EM, Nsaibirini R, Buri D, Yuya F, Youm E, Ntone R, Mbarga NF, Matchim L, Tchiasso D, Ngosso A, Nanda E, Yonta C, Ndifon M, Essomba RG, Wanda F, Mandeng N, Essaka R, Koku MT, Eyangoh S, Ousman M, Esso L, Epee E, Njouom R, Okomo MC, Ciglenecki I, Mballa GAE, Issoufou SH, Porten K, Boum Y II
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
BACKGROUND
Although the first year of the COVID-19 pandemic in Africa did not produce the expected catastrophe, the true impact of COVID-19 in the Cameroonian population was unclear. We therefore assessed the seroprevalence of anti-SARS-CoV-2 antibodies and retrospective mortality in a representative sample of the general population in the 10 administrative regions of Cameroon more than one year after the first confirmed cases of COVID-19 in these regions. We aimed to assess the extent of SARS-COV-2 infection and to detect potential increases in the crude mortality rate (CMR) during the SARS-COV-2 pandemic phase.

METHODS
We assessed retrospective mortality and seroprevalence of anti-SARS-CoV-2 antibodies in the 10 capital cities of Cameroon using representative samples of the general population. The study included nested anti-SARS-CoV-2 antibody prevalence surveys and retrospective mortality surveys and was conducted between 27 July 2021 and 31 August 2021. To further analyse crude mortality rates by age group and COVID wave, pre-pandemic and pandemic periods were stratified. Both laboratory-based assays (ELFA) and rapid diagnostic tests (RDT) were used to measure anti-SARS-CoV-2 seroprevalence.

RESULTS
The crude mortality rate (CMR) increased from 0.06 deaths per 10 000 persons per day (pre-pandemic) to 0.17 deaths per 10 000 persons per day (pandemic). The increase in CMR was more pronounced in people aged 20-35 years (pre-pandemic 0.02 deaths per 10 000 persons per day; pandemic 0.06 deaths per 10 000 persons per day). The estimated seroprevalence among unvaccinated persons was 9.5% (RDT) and 15.4% (laboratory-based).

CONCLUSION
The seroprevalence results showed that cases were significantly underdetected by the national surveillance systems.

Countries

Cameroon

Subject Area

Covid-19disease surveillancemortality

Languages

English
DOI
10.1016/j.sciaf.2023.e01925
Published Date
04 Oct 2023
Journal
Scientific African
Volume | Issue | Pages
Online ahead of print, Pages e01925
Dimensions Badge